Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

JANSSEN - CILAG FARMACÊUTICA LDA

NIF 500189412
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €24,814,006 151 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €24,814,006 151 contracts
A2 · Late Publication €42,712,129,159 4,935 contracts
Contract published to BASE more than 10 days after the signing date
LOW €42,712,129,159 4,935 contracts
A5 · Threshold Splitting €22,743,051 177 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €22,743,051 177 contracts
A6 · Low Competition €91,915,793 97 contracts
Only one bidder participated in a competitive procedure
MEDIUM €91,915,793 97 contracts
A9 · Price Overrun €50,998 5 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €12,223 3 contracts
MEDIUM €38,775 2 contracts
A9 · Abnormal Price Reduction €49,772,190,889 1,586 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €49,772,190,889 1,586 contracts
B5 · Benford's Law Deviation €1,119,077,276 4 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €1,119,077,276 4 contracts
C3 · Missing Mandatory Fields €45,926,897 112 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €45,926,897 112 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

693
€6,293,597,958
51
€4,427,745,954
117
€2,755,649,371
512
€1,547,449,221
127
€1,465,498,131
70
€1,451,746,778
91
€1,404,595,235
225
€1,393,538,222
160
€1,387,505,100
264
€1,384,325,190
77
€1,371,811,757
42
€1,345,899,313
474
€1,321,027,153
359
€1,248,942,630
31
€1,247,538,126
44
€1,222,389,256
47
€1,218,900,423
46
€1,207,957,071
101
€1,152,390,544
216
€1,113,648,059
Page 1 of 4 · 70 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 4 · 151 contracts

AQUISIÇÃO URGENTE VARIOS MEDICAMENTOS
PT · 11859921 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€0 2025-10-03
AQUISIÇÃO URGENTE DE VARIOS MEDICAMENTOS
PT · 11978826 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€68,900 2025-09-30
AQ. URGENTE DIVERSOS MEDICAMENTOS
PT · 11986613 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€78,851 2025-09-02
AQUISIÇAO URGENTE VARIOS MEDICAMENTOS
PT · 11982587 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€26,027 2025-09-02
1358/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de B466 - BOSENTANO [32 MG; COMP DISP], B925 - BEDAQUILINA [100 MG; CÁP/COMP], T1818 - TECLISTAMAB [90 MG/ML; 1,7 ML; SO
PT · 11762838 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€6,320,496 2025-08-19
AQUISIÇÃO URGENTE DE DIVERSOS MEDICAMENTOS
PT · 11943695 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€60,815 2025-08-07
AQ URGENTE MEDICAMENTOS VÁRIOS
PT · 11944307 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€52,561 2025-08-07
AQUISIÇÃO URGENTE MEDICAMENTOS
PT · 12015523 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€47,530 2025-07-10
Aquisição de AMIVANTAMAB 50MG/ML IV INJ (Janssen)
PT · 11645524 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€140,421 2025-07-03
Aquisição de USTECINUMAB 45 MG/0,5ML SC INJ SERINGA
PT · 11631388 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€48,192 2025-06-26
VÁRIOS MEDICAMENTOS
PT · 11525610 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€10,728 2025-05-29
Aquisição Medicamento talquetamab inj. 2mg/ml 1.5ml sc e talquetamab inj. 40mg/1ml sc
PT · 11738150 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€147,705 2025-05-28
VÁRIOS MEDICAMENTOS
PT · 11472462 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€32,660 2025-05-27
PALIPERIDONA 50 MG SUSP INJ LP SER IM
PT · 11468241 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€2,299 2025-05-20
VÁRIOS MEDICAMENTOS
PT · 11447658 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€92,803 2025-05-16
VÁRIOS MEDICAMENTOS
PT · 11425193 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€108,378 2025-05-06
USTECINUMAB 130 MG/26 ML SOL INJ FR 26 ML IV - STELARA
PT · 11458125 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€72,491 2025-04-16
AMIVANTAMAB
PT · 11460018 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€147,734 2025-04-14
MEDICAMENTOS
PT · 11344512 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€47,601 2025-04-11
VÁRIOS MEDICAMENTOS
PT · 11361526 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€66,019 2025-04-07
VÁRIOS MEDICAMENTOS
PT · 11336893 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€26,845 2025-03-31
VÁRIOS MEDICAMENTOS
PT · 11315143 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€43,093 2025-03-25
VÁRIOS MEDICAMENTOS
PT · 11305524 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€22,274 2025-03-19
Ustecinumab Caneta
PT · 11457760 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€279,232 2025-03-14
VÁRIOS MEDICAMENTOS
PT · 11304485 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€11,707 2025-03-14
VÁRIOS MEDICAMENTOS
PT · 11284920 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€12,379 2025-03-10
1358/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de B466 - BOSENTANO [32 MG; COMP DISP], B925 - BEDAQUILINA [100 MG; CÁP/COMP], T1818 - TECLISTAMAB [90 MG/ML; 1,7 ML; SO
PT · 11254803 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A9 · Abnormal Price Reduction +1
€6,320,496 2025-02-25
VÁRIOS MEDICAMENTOS
PT · 11306751 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€43,704 2025-02-24
VÁRIOS MEDICAMENTOS
PT · 11261635 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€20,080 2025-02-24
VÁRIOS MEDICAMENTOS
PT · 11233577 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€16,494 2025-02-13
1246/2024 - Convite à apresentação de proposta por ajuste direto para aquisição de B466 - BOSENTANO [32 MG; COMP DISP] B925 - BEDAQUILINA [100 MG; CÁP/COMP] T1818 - TECLISTAMAB [90 MG/ML; 1,7 ML; SOL
PT · 11928169 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€893,802 2025-02-06
Aquisição medicamento paliperidona inj.lib.prol. 700mg _1000mg e bedaquilina comp 100mg
PT · 11756745 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€256,789 2025-01-20
1246/2024 - Convite à apresentação de proposta por ajuste direto para aquisição de B466 - BOSENTANO [32 MG; COMP DISP] B925 - BEDAQUILINA [100 MG; CÁP/COMP] T1818 - TECLISTAMAB [90 MG/ML; 1,7 ML; SOL
PT · 11181443 · Ajuste Direto Regime G...
A1 · Repeat Direct Award C3 · Missing Mandatory Fields +1
€2,352 2024-12-20
USTECINUMAB
PT · 11191481 · Ajuste Direto Regime G...
A1 · Repeat Direct Award C3 · Missing Mandatory Fields
€85,845 2024-12-10
Aquisição Medicamento Infliximab inj. 100mg iv
PT · 11016024 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€6,982 2024-11-07
Aquisição Medicamento ustecinumab inj. 90mg/1ml sc
PT · 11334323 · Ajuste Direto Regime G...
A1 · Repeat Direct Award C3 · Missing Mandatory Fields
€305,228 2024-11-07
Paliperidona e Risperidona
PT · 11072240 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€3,496 2024-10-28
Aquisição medicamento teclistamab 10mg_ml e teclistamab 90mg_ml inj
PT · 11003589 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€176,928 2024-10-23
VÁRIOS MEDICAMENTOS
PT · 10860967 · Ajuste Direto Regime G...
A2 · Late Publication A1 · Repeat Direct Award
€48,180 2024-07-26
Medicamento Daratumumab 120mg/ml sol inj
PT · 10735563 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€166,647 2024-05-23
VÁRIOS MEDICAMENTOS
PT · 10738006 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€24,546 2024-04-30
Medicamento Bedaquilina CP 100 mg
PT · 11349715 · Ajuste Direto Regime G...
A1 · Repeat Direct Award C3 · Missing Mandatory Fields
€30,585 2024-04-18
VÁRIOS MEDICAMENTOS
PT · 10672962 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€14,952 2024-03-25
897/2024 - Convite à apresentação de proposta por ajuste direto para aquisição de B466-BOSENTANO [32 MG; COMP/DISP]
PT · 10919517 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +2
€92,552 2024-03-22
10000009232024 - Epoetina alfa 40000 U.I./1 ml
PT · 10781231 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€1,441 2024-02-28
738/2023 - Convite à apresentação de proposta por ajuste direto para aquisição de BOSENTANO [32 MG; COMP/DISP]
PT · 10761007 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +2
€20,798 2024-01-13
Medicamento Teclistamab inj 90mg/1.7ml
PT · 10808411 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€23,136 2023-11-29
AD/1504/2023 - Ustecinumab 90mg/1ml ao abrigo do AQ 2021/6
PT · 10361640 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€481,939 2023-11-22
Medicamento Ustecinumab inj. 90mg/ 1 ml
PT · 10372480 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€80,323 2023-11-21
VÁRIOS MEDICAMENTOS
PT · 10346210 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€12,027 2023-11-13
Next →
Overview
Total Value Won
€50,579,567,987
Contracts Won
7,070
Score 231630 · CRITICAL RISK
NIF
500189412
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned